Newnal

For the last decade, Blockchain Labs (BCL) has been developing blockchain-based infrastructure that operates without cryptocurrency to offer groundbreaking security and scalability for sensitive and proprietary data. BCL's globally patented technology, InfraBlockchainⓅ, enables secure, transparent, cost-effective applications for various industries. In 2020, BCL developed the COOV app, the world's first blockchain-based vaccine pass, accepted in 120+ countries globally and used by over 43 million people, 30+ million times a day. After raising a Series A in 2022, BCL embarked on its most ambitious project, Newnal. Newnal offers unprecedented precision and privacy in generative AI by ensuring sensitive data's utmost integrity, security, and reliability. Newnal redefines how data is handled – transforming the landscape of B2B and B2C AI applications where trust and precision are non-negotiable. Blockchain Labs is headquartered in Seoul and has an office in San Francisco. For more information, visit bc-labs.net/en